HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petäjä, J. Articles by Siimes, M. A. Search for Related Content PubMed PubMed Citation Articles by Petäjä, J. Articles by Siimes, M. A.

J Thorac Cardiovasc Surg 1995;109:524-529
© 1995 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

Bleeding and use of blood products after heart operations in infants

Helsinki, Finland

From Children's Hospital, University of Helsinki, Finland.

Received for publication March 10, 1994. Accepted for publication July 29, 1994. Address for reprints: Jari Petäjä, MD, Children's Hospital, University of Helsinki, Stenbackinkatu 11, FIN-00290 Helsinki, Finland.

Abstract

Recent studies have suggested that postoperative bleeding is decreased in pediatric heart operations if fresh whole blood instead of blood component therapy is used for postoperative transfusions. Because this is in contrast to our practice to use whole blood for only the priming of the cardiopulmonary bypass circuit and then to use blood components for additional transfusion requirements, it was our interest to analyze the bleeding complications and the use of blood products after heart operations in infants. The patient records of the 73 infants operated on in 1992 were reviewed. The chest tube drainage varied from 3 to 51 ml/kg per 6 hours (mean 10 ml/kg) and it did not correlate with any of the tested clinical or laboratory parameters. One infant underwent reoperation because of surgical bleeding. Disseminated intravascular coagulation developed in another patient. Sixty-eight patients (93%) needed red blood cell supplementation. Sixty-eight percent of patients between 1 month and 1 year old could be treated without any other postoperative transfusion except for red blood cell supplementation. In contrast, in the neonates, platelet concentratesor fresh frozen palsma, or both, were used in 61% of the patients. In addition to the known immaturity of the hemostatic system, the increased need for platelet concentrates in the neonates was attributed to longer cardiopulmonary bypass time, deeper hypothermia in association with circulatory arrest, larger dosages of heparin, and more extensive plasma dilution during cardiopulmonary bypass. In conclusion, a low rate of bleeding complications and acceptably low general blood loss can be achieved postoperatively with blood component therapy. (J THORACCARDIOVASCSURG1995; 109: 524-9)

This article has been cited by other articles:

				A. Szekely, Z. Cserep, E. Sapi, T. Breuer, C. A. Nagy, P. Vargha, I. Hartyanszky, A. Szatmari, and A. Treszl Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations Ann. Thorac. Surg., January 1, 2009; 87(1): 187 - 197. [Abstract] [Full Text] [PDF]

				H. D. Golab, T. V. Scohy, P. L. de Jong, J. J.M. Takkenberg, and A. J.J.C. Bogers Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 354 - 359. [Abstract] [Full Text] [PDF]

				M. P. Eaton Antifibrinolytic Therapy in Surgery for Congenital Heart Disease Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100. [Abstract] [Full Text] [PDF]

				H. D. Golab, J. J.M. Takkenberg, G. L. van Gerner-Weelink, M. J. Wijers, T. V. Scohy, P. L. de Jong, and A. J.J.C. Bogers Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 335 - 339. [Abstract] [Full Text] [PDF]

				E. Hickey, T. Karamlou, J. You, and R. M. Ungerleider Effects of Circuit Miniaturization in Reducing Inflammatory Response to Infant Cardiopulmonary Bypass by Elimination of Allogeneic Blood Products Ann. Thorac. Surg., June 1, 2006; 81(6): S2367 - S2372. [Abstract] [Full Text] [PDF]

				S. S. Mou, B. P. Giroir, E. A. Molitor-Kirsch, S. R. Leonard, H. Nikaidoh, F. Nizzi, D. A. Town, L. C. Roy, W. Scott, and D. Stromberg Fresh Whole Blood versus Reconstituted Blood for Pump Priming in Heart Surgery in Infants N. Engl. J. Med., October 14, 2004; 351(16): 1635 - 1644. [Abstract] [Full Text] [PDF]

				M. M. McCall, M. M. Blackwell, J. T. Smyre, J. J. Sistino, J. R. Acsell, B. H. Dorman, and S. M. Bradley Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial Ann. Thorac. Surg., March 1, 2004; 77(3): 983 - 987. [Abstract] [Full Text] [PDF]

				W. C. Oliver Jr Overview of Heparin and Protamine Management and Dosing Regimens in Pediatric Cardiac Surgical Patients Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 387 - 410. [Abstract] [PDF]

				W. C. Oliver Jr, F. M. Beynen, G. A. Nuttall, D. R. Schroeder, M. H. Ereth, J. A. Dearani, and F. J. Puga Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime Ann. Thorac. Surg., May 1, 2003; 75(5): 1506 - 1512. [Abstract] [Full Text] [PDF]

				G. D. Williams, S. L. Bratton, E. C. Riley, and C. Ramamoorthy Association between age and blood loss in children undergoing open heart operations Ann. Thorac. Surg., September 1, 1998; 66(3): 870 - 875. [Abstract] [Full Text] [PDF]

				J. Petaja, U. Lundstrom, H. Sairanen, E. Marttinen, and J. H. Griffin CENTRAL VENOUS THROMBOSIS AFTER CARDIAC OPERATIONS IN CHILDREN J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 883 - 889. [Abstract] [Full Text]